PNTG (Health Care Services) Stock Valuation & Fair Value Significantly overvalued
PNTG (Health Care Services) trades at a blended P/E of 32.0, about 9% below its historical normal valuation, with a forward growth estimate of 15.0% and a PEG of 2.14. Analysts' one-year estimates have been hit 33% of the time.
Valuation flags
- No notable valuation flags.
Frequently asked questions
Is PNTG overvalued?
At a blended P/E of 32.0 versus its historical normal P/E of 35.1, PNTG trades about 9% below its typical valuation, with a PEG of 2.14 on 15.0% forward growth. tickerseer currently rates it significantly overvalued.
What is PNTG's fair value and PEG?
PNTG trades at a blended P/E of 32.0 against a historical normal P/E of 35.1, a PEG of 2.14, and a forward growth estimate of 15.0%.
Has tickerseer's rating of PNTG changed?
tickerseer's rating has been significantly overvalued since 2026-07-31.
Industry: Health Care Services. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.
Get the free weekly earnings preview
One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in the paid plan.
It's free, and you can unsubscribe any time. Educational content, not investment advice.